viewTissue Regenix Group PLC

Tissue Regenix receives CE mark for OrthoPure XT

The regenerative medicine firm said the CE mark permits the use of OrthoPure XT for the reconstruction of knee ligaments, including multi-ligament procedures following trauma

Tissue Regenix Group PLC - Tissue Regenix receives CE mark for OrthoPure XT

Tissue Regenix Group PLC (LON:TRX) said its OrthoPure XT product has been awarded a CE mark following a single arm, non-comparative, prospective study undertaken over three years.

The regenerative medical devices specialist said the CE mark has been awarded for revision of the anterior cruciate ligament following re-rupture and also permits use for the reconstruction of other knee ligaments, including multi-ligament procedures following trauma.

READ: Tissue Regenix raises cash to expand manufacturing capacity in the US

OrthoPure XT is a decellularised xenograft ligament that enables tissue regeneration, utilising the group's dCELL technology, originally created at the University of Leeds.

"I am delighted that the company has been successful in being awarded a CE mark for OrthoPure XT, this represents an important milestone in our product portfolio evolution”, said interim chief executive Gareth Jones.

“The board remains committed to reviewing the overall strategy for both existing and potential products, to ensure cash resources are deployed efficiently and our corporate objectives are met", he added.

Shares in Tissue Regenix surged 22.7% to 0.5p in early trading on Monday.

Quick facts: Tissue Regenix Group PLC

Price: 0.33 GBX

Market: AIM
Market Cap: £23.21 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...



Morning Report: FTSE 100 heads higher as markets welcome easing of restrictions

Headlines from the Proactive UK newsroom. The FTSE 100 rose 21 points to 6,957 as markets welcomed more easing of coronavirus lockdown measures across Europe despite some confusion in the UK. UK prime minister Boris Johnson, though, is being pressed for more clarity on the relaxation of UK...

on 11/5/20

2 min read